Intellectual Property Valuation for a British biotech
Suggested Case Studies
Website created by BrandedbyAaliya
© 2023 Ideal Capital Management Consultants LLC.
All rights reserved.
Check out a back issue of our newsletter here.
Contact Us
Assignment
A UK-based biotech company owning multiple advanced drug delivery patents approached us to determine an independent valuation for its biotech portfolio of assets.
Our Approach
Outcome
We determined the independent revenue streams for each patent and benchmarked the assumption by researching industry-recognized databases, such as pharmaceutical industry IMS and WIPO data sets.
We then computed the Risk-adjusted Net Present Value (rNPV) for capturing the progressive success rate during each stage of drug development through multiple clinical trials and the New Drug Application (NDA) approval process.
Our detailed risk evaluation through the rNPV approach enabled our client to confidently negotiate with investors during the fund-raising process.